Beskrovnaya Oxana

Chief Scientific Officer | See Remarks

1 company

Good

Trades Analyzed

12M Win Rate

54.2%

Avg 3M Return

-5.9%

Avg 12M Return

-7.6%

Beskrovnaya Oxana is a Chief Scientific Officer at Dyne Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 14 sells.

Estimated insider holdings value: $4.1M based on current market prices.

Holdings by Company

DYNMar 11, 2025

Current Shares195.8K

Value$4.06M

Net Activity-155,766

Bought: 0Sold: 155.8K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 16, 2024	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	2,705	$28.27	$76,469.37	-0.9%	+52.6%	-58.9%
Mar 11, 2024	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	2,081	$25.70	$53,481.70	-1.3%	+23.3%	-52.9%
Mar 7, 2024	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	2,373	$25.85	$61,342.05	-1.5%	+24.4%	-53.1%
Jan 4, 2024	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sale+OE	87,779	$18.57	$1,629,985.42	-10.8%	+48.3%	+27.7%
Dec 11, 2023	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	1,467	$10.72	$15,726.24	-0.8%	+134.4%	+159.9%
Sep 18, 2023	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	1,436	$9.41	$13,512.76	-1.7%	+21.1%	+251.3%
Sep 12, 2023	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	1,484	$10.41	$15,448.44	-1.7%	+10.1%	+229.3%
Jun 13, 2023	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	1,475	$12.43	$18,334.25	-1.7%	-13.1%	+156.5%
Mar 14, 2023	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	1,416	$13.33	$18,875.28	-1.6%	-7.3%	+105.7%
Dec 12, 2022	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	680	$10.87	$7,391.60	-0.7%	+13.1%	-5.9%